Begin Treatment With OPSYNVI® Today
Follow these 3 steps to get your patients with PAH started on OPSYNVI® (macitentan/tadalafil):
Complete
the Enrollment and Prescription Form
Verify
your patient’s insurance
Contact
a specialty pharmacy
Complete the Enrollment and Prescription Form
After prescribing OPSYNVI® (macitentan/
tadalafil), there are 2 forms your healthcare team needs to fill out before moving forward.
Patient Authorization Form
A release form that allows providers, insurers, and Johnson & Johnson to share medical information about your patients.
Enrollment and Prescription Form
A form required to get your patient started on OPSYNVI®. It also includes information on access and voucher programs.
Verify your patient’s insurance
Your patient’s insurance company may need more information before approving OPSYNVI®. This may include prior authorizations, exceptions, and appeals. Visit www.jnjwithme.com or reach out to a Care Coordinator for assistance.
Care Coordinators can look into a patient’s insurance coverage, support
the prior authorization process, and more.
What does current coverage look like?
- 60% of OPSYNVI® coverage does not have a step requirement1*
What might that mean for your patients?
- Some insurers may require starting on a PDE5i or ERA before covering OPSYNVI®
- Review local coverage and step therapy requirements with your Therapy Access Manager (TAM), using the most current plan data
Contact a specialty pharmacy
OPSYNVI® is only available through specialty pharmacies, which deliver it to patients by mail. When your patients are enrolled, they are connected to a specialty pharmacy based on their health insurance or an indicated preference.
The following are specialty pharmacies that can provide OPSYNVI® to your patients:
Average time to approval for OPSYNVI® (19.5 days) is comparable to OPSUMIT® (17.8 days)
J&J withMe offers support through Therapy Access Managers who can educate on payer-specific requirements and reduce delays, and Care Coordinators who can assist with benefits verification and cost support options.
The patient support and resources provided by J&J withMe are not intended to provide medical advice, replace a treatment plan from the patient's doctor or nurse, provide case management services, or serve as a reason to prescribe a J&J medicine.
Review patient cases
and see if OPSYNVI® is right for your patients with PAH